Here is a stock report on five publicly traded GI/endoscopy companies for April 13 to April 17.
• AbbVie: $62.29 per share (down 0.48 percent)
• Boston Scientific: $18.26 per share (up 0.58 percent)
• FUJIFILM Holdings: $38.56 per share (up 0.56 percent)
• Olympus: $36.90 per share (down 1.13 percent)
• Valeant Pharmaceuticals: $204.50 per share (down 1.38 percent)
More articles on gastroenterology:
CMS: Guidance on colonoscopy anesthesia modifier, X modifiers
Alternative payment models in GI: What’s on the horizon?
3 GI physicians making headlines – April 17, 2015
Gastroenterologists are facing increasing financial strain as reimbursement rates continue to decline. A study published in The American Journal of…
Law firm Edelson Lechtzin is investigating privacy violations at Gastroenterology Associates of Central Florida, also known as the Center for…
A case in front of the U.S. Supreme Court could limit the U.S. Preventive Services Task Force's role in preventive…